B+
Bull case
0%
Probability
Target price
$335.00
+31.7% vs current
ZBRA
ZebraCNasdaq / Technology Hardware & Equipment
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
1%
Probability
Target price
$285.00
+12.0% vs current
B-
Bear case
0%
Probability
Target price
$225.00
-11.6% vs current
AI sentiment snapshot
Latest data as of 2026-05-15
Recent news sentiment (30D)
+6.6
Positive
Company
+17.2
Positive
Macro
+7.9
Positive
Pulse
-35.0
Negative
Sentiment proxy
+62.2
Score
AI commentary
Tone improved materially after the May 12, 2026 print because the company delivered a beat/raise and trusted follow-up coverage described a double-digit immediate share-price rally tied to the results and higher outlook. By the May 14, 2026 anchor, some of that enthusiasm had already normalized, which fits a constructive-but-not-euphoric setup. Coverage is adequate on the earnings event, but visible analyst revision breadth is still incomplete, so confidence should stay moderate rather than high.
RankAlpha Sentiment Codex - 2026-05-15
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-12eventQ1 beat-and-raise resets the near-term earnings base [#8-K-2026-05-12]High impact
Zebra reported Q1 net sales of $1.495B (+14.3% YoY), non-GAAP EPS of $4.75, and raised FY2026 guidance to 10%-14% sales growth, about 22% adjusted EBITDA margin, $18.30-$18.70 non-GAAP EPS, and >$900M free cash flow; the company also guided Q2 sales growth to 14%-17%.
2026-05-31catalystCapital return and post-print analyst follow-through can support a near-term reratingMedium impact
The 10-Q disclosed $300M of Q1 buybacks plus another roughly $200M repurchased early in Q2, while post-earnings follow-up coverage showed at least some supportive sell-side reaction, including KeyBanc upgrading to Overweight with a $305 target and UBS raising its target to $335 from $310.
2026-08-01catalystOrganic growth plus acquisition synergies remain the main medium-term execution test [#10-Q-2026-05-12]High impact
Q1 consolidated organic growth was 4.3%, with CF organic growth of 3.8% and AVA organic growth of 4.8%; CF growth still benefited from Elo Touch while AVA benefited from printing strength, so the next leg of upside depends on sustaining organic demand and converting Elo/Photoneo integration into durable margin support.
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-15 • Updated nightlySource: Internal modelMethodology